Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 551Colorectal Neoplasms 246Neoplasms 232Prostatic Neoplasms 221Carcinoma, Non-Small-Cell Lung 196Stomach Neoplasms 153Leukemia, Myeloid, Acute 149Carcinoma, Hepatocellular 147Lung Neoplasms 136Rectal Neoplasms 135Multiple Myeloma 132Nasopharyngeal Carcinoma 111Colonic Neoplasms 106Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Lymphoma 85Uterine Cervical Neoplasms 83Pancreatic Neoplasms 82Lymphoma, Large B-Cell, Diffuse 79Ovarian Neoplasms 78Leukemia 78Head and Neck Neoplasms 77Esophageal Neoplasms 74Lymphoma, Follicular 72Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 65Recurrence 64Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 58Pain 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Localized Prostate Cancer × Clear all
NCT06825091 2026-01-28

ASPIRE

University Health Network, Toronto

Phase 3 Recruiting
320 enrolled
Genitourinary

Localized Prostate Cancer

NCT00196781 2010-01-13

Treatment Decision Making in Early-Stage Prostate Cancer

Georgetown University

Phase 3 Completed
168 enrolled
Genitourinary

Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡